AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06644547 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gezond en goed met elkaar
Description: The intervention 'Gezond en goed met elkaar' focuses on improving (positive) health literacy and literacy. The six domains of positive health are the focus of the intervention meetings. This intervention has been made available for citizens of Almere, Zwolle, Gouda, Nunspeet and Leusden through collaboration with these municipalities. Lifestyle coaches working in these municipalities implement the intervention.
Study NCT04416815 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Integrating Health promotion with and for Older People - eHealth
Description: The intervention will be delivered for 6 months on top of usual care. It will be provided by HCPs. If needed one home visit to install the digital platform will be conducted. A HCP will introduce how to use the digital platform and create a personal account. The intervention starts with a person-centred phone-call where a health plan is co-created and potential team members to support this are identified and invited. The health plan includes the older persons' goals, internal and external resources, and need of support from health and/or social-services. This plan will be the point of departure for the forthcoming dialogue. A digital platform will open up for extended and safe communication and visualize the health planning between the older person and team-members in different settings. The older person and the HCP and involved team members on the digital platform will regularly evaluate the health plan and commonly agreed goals.
Study NCT04287829 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Infusion
Study NCT04287829 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Capsule
Study NCT06232993 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Description: Kinesio taping is a technique that involves the application of a special elastic tape to the skin to provide support to muscles and joints without restricting the body's range of motion. This method is designed to facilitate the body's natural healing process and improve muscle function while providing support and stability to muscles and joints. Kinesio tape is believed to help reduce pain, support muscles during movement, and aid in rehabilitation. It is commonly used in sports medicine and physical therapy to address a variety of musculoskeletal conditions and injuries.
Study NCT06232993 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Occlusal Splinting
Description: Occlusal splinting, also known as a bite guard or night guard, is a removable dental appliance typically made of plastic that is custom-fitted to a patient's upper or lower teeth. It is primarily used to address issues related to teeth grinding (bruxism) or temporomandibular joint (TMJ) disorders. The splint is designed to fit over the teeth, creating a barrier between the upper and lower teeth to prevent grinding and clenching during sleep. Occlusal splints aim to reduce the impact of bruxism on the teeth and jaw, alleviate associated pain, protect the teeth from wear, and promote relaxation of the jaw muscles.
Study NCT06232993 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercises
Description: For patients with bruxism, exercises can be beneficial in managing symptoms and promoting relaxation of the jaw muscles. These exercises aim to reduce the frequency and intensity of bruxism, alleviate associated pain, and improve overall jaw function and comfort. It's important for patients to consult with healthcare professionals to determine the most appropriate exercises for their individual needs.
Study NCT05837897 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vedolizumab IV
Description: Vedolizumab IV infusion
Study NCT05837897 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Vedolizumab placebo-matching IV infusion
Study NCT04543786 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous spinal cord stimulation
Description: Neuromodulation with transcutaneous spinal cord stimulation applied on lower back adjacent to spine for 30-60 minutes for 5 consecutive days.
Study NCT06082843 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo matching Avenciguat (BI 685509)
Study NCT06082843 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avenciguat (BI 685509)
Description: Avenciguat (BI 685509)
Study NCT06635122 — intervention group
Intervention type: PROCEDURE
Intervention: Transjugular intrahepatic portosystemic shunt
Description: Transjugular intrahepatic portosystemic shunt (TIPS) is a procedure that uses imaging guidance to connect the portal vein to the hepatic vein in the liver. The TIPS-dedicated stent (Gore, Arizona, USA)was emplaced within the liver and gradually expanded utilizing a balloon with a diameter ranging from 6 to 10 millimeters, aiming for a decrease in portal-venous pressure gradient to less than 12 mmHg or achieve a reduction of 25 to 50% relative to the baseline pressure.
Study NCT06635122 — intervention group
Intervention type: PROCEDURE
Intervention: Endoscopic treatment
Description: Endoscopic variceal ligation, endoscopic injection sclerotherapy, endoscopic variceal histoacryl injection therapy , or a combination of several methods were selected according to the location, size, and shape of the patient's varicose veins.Treatment failure can be transferred to TIPS therapy.
Study NCT06313866 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: control
Description: Donepezil hydrochloride was administered at 5 mg once a day (nightly) for 30 days without adverse reactions and then increased to 10 mg once a day (nightly) for 4 weeks.
Study NCT06313866 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronuchal acupuncture group treatment
Description: Electronuchal acupuncture
Study NCT06313866 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Smell therapy group treatment
Description: nasal suction intervention with volatile oil of Acorus calamus
Study NCT06313866 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Smell therapy group treatment
Description: nasal suction intervention with volatile oil of Acorus calamus
Study NCT06313866 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronuchal acupuncture combined with smell and inhalation therapy group treatment
Description: On the basis of electric nuchal acupuncture treatment, sniffing and inhalation therapy is given.
Study NCT06313866 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: In the sham stimulation group, non-transdermal comfortable acupuncture will be used to make the patients experience a feeling similar to acupuncture.
Study NCT05830097 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBP-1019
Description: Light yellow to yellow loose lumps or powder；50mg/vial; Infusion for 90 minutes (± 10 minutes), once every 2 weeks.
Study NCT05383898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D-1553
Description: D-1553 is a novel, targeted KRasG12C inhibitor that is being developed as a potential oral agent for advanced or metastatic solid tumors with KRasG12C mutation.
Study NCT04874610 — intervention group
Intervention type: DRUG
Intervention: Methylprednisolone
Description: Administration of methylprednisolone Prescribed per Standard of care
Study NCT05378581 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality mask
Description: virtual reality mask Deepsen® with age-appropriate software Birdy®
Study NCT06275971 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SMBG or venous/arterial blood glucose
Description: Glycemic control was monitored using SMBG or venous/arterial blood glucose data for seven days following cardiac surgery
Study NCT06253312 — intervention group
Intervention type: PROCEDURE
Intervention: Open surgery
Description: Patients with complex TASC C and D aortoiliac occlusive disease undergoing open surgery: aortobifemoral bypass, crossover bypass, axillobifemoral bypass, aortoiliac endarterectomy, iliofemoral bypass
Study NCT06253312 — intervention group
Intervention type: PROCEDURE
Intervention: Hybrid repair
Description: Patients with complex TASC C and D aortoiliac occlusive disease undergoing simultaneous open surgical femoral artery reconstruction (endarterectomy, bypass, profundoplasty) and stenting of the iliac axis
Study NCT06253312 — intervention group
Intervention type: PROCEDURE
Intervention: Endovascular repair
Description: Patients with complex TASC C and D aortoiliac occlusive disease undergoing total endovascular repair using different material: bare metal stents (self and balloon expandable), stent-grafts (self and balloon expandable), covered endovascular reconstruction of aortic bifurcation (CERAB), simple plain old balloon angioplasty (POBA)
Study NCT05378581 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: control arm
Description: usual process
Study NCT04598087 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prehabilitation
Description: The multi-phasic prehabilitation intervention involves three phases: Phase 1: Before surgery (typically \~25 days); Phase 2: The in-hospital phase (typically 10-14 days); Phase 3: Discharge to 6-weeks after surgery.
Study NCT04858256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pacritinib
Description: Pacritinib will be dosed at 200mg twice daily.
Study NCT06409195 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SM-020 1% Gel
Description: SM-020 gel 1.0% will be applied topically. Subjects will be treated with twice daily application to at least 1 and up to 5 Target Lesions (TLs) for 28 days.
Study NCT05909943 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Description: Treatment with ruxolitinib will be initiated in an initial dose regimen of 5-10 mg twice daily. Two months later, the dose of ruxolitinib will be increased to 10-15 mg twice daily.
Study NCT05066451 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: %5 dextrose prolotherapy
Description: Patients in the study group will receive a total of 3 sessions of prolotherapy solution containing 5% dextrose at the beginning(0.) 3rd week and 6th week.~Prolotherapy was planned with the multiplanar injection technique (peppering technique) after palpating the most sensitive point on the lateral epicondyle and entering the lateral epicondyle from here and ensuring bone contact.
Study NCT05066451 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: %15 dextrose prolotherapy
Description: Patients in the study group will receive a total of 3 sessions of prolotherapy solution containing 15% dextrose at the beginning(0.) 3rd week and 6th week.~Prolotherapy was planned with the multiplanar injection technique (peppering technique) after palpating the most sensitive point on the lateral epicondyle and entering the lateral epicondyle from here and ensuring bone contact.
Study NCT06058559 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sunflower lecithin
Description: Lecithins are a group of essential phospholipids that are involved in a number of biological functions such as lipid-cholesterol transport, transmembrane signaling, and neurological function
Study NCT06058559 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Olive oil
Description: Extra virgin olive oil
Study NCT04363177 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Web-based psychosocial peer-to-peer support
Description: The evidence-based eHealth peer-to-peer psychosocial intervention Thinking Healthy, will be tested in this RCT. In line with the World Health Organization's mhGAP Intervention Guide (mhGAP-IG), Thinking Healthy is used to identify and manage perinatal mental health conditions (distress, symptoms of depression, and anxiety) in non-specialized psychosocial support setting.
Study NCT04363177 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-based psychosocial peer-to-peer support
Description: The evidence-based eHealth peer-to-peer psychosocial intervention Thinking Healthy, will be tested in this RCT. In line with the World Health Organization's mhGAP Intervention Guide (mhGAP-IG), Thinking Healthy is used to identify and manage perinatal mental health conditions (distress, symptoms of depression, and anxiety) in non-specialized psychosocial support setting.
Study NCT05517551 — intervention group
Intervention type: PROCEDURE
Intervention: robotic assisted radical prostatectomy
Description: Patients who will undergo robotic-assisted laparoscopic prostatectomy surgery
Study NCT06434818 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: EDITOR (CBOT with olfactory stimulants, OFC tasks & remote monitoring of treatment compliance)
Description: EDITOR includes a user-friendly cloud portal synced with the main device, providing a comprehensive training program for the orbitofrontal cortex (OFC). The main device stimulates the orbitofrontal cortex intensely, preventing habituation to smells and improving adaptability. This enhances neurobehavioral plasticity, benefiting Substance Use Disorder (SUD) outcomes. The device also features a 60% beta-caryophyllene scent for addressing issues like Alcohol Use Disorder and stimulant use disorders. With ten digital enhancements, it enables remote treatment and data collection, seamlessly transmitting information to healthcare providers through a secure, HIPAA-compliant portal.
Study NCT06434818 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: CBOT with olfactory stimulants & OFC tasks
Description: The CBOT with proprietary odorant molecules is designed to stimulate olfactory neural activity over long periods of time combined with orbitofrontal cortex (OFC) dependent olfactory tasks.
Study NCT06434818 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: SHAM_COMPARATOR
Intervention: CBOT Sham
Description: CBOT Sham uses artificially scented compressed room air instead of olfactory stimulants and has control cognitive olfactory tasks
Study NCT04229979 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Galinpepimut-S
Description: Galinpepimut-S admixed with the adjuvant Montanide following specified schedule
Study NCT04229979 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azacitidine
Description: injection
Study NCT04229979 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Venetoclax
Description: tablet
Study NCT04229979 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Decitabine
Description: injection
Study NCT06260501 — intervention group
Intervention type: OTHER
Intervention: super-wet technique
Description: Liposuction with super-wet technique using wetting-solution containing 0.5 gr lidocaine and 0.5 mg epinephrine in each liter
Study NCT04229979 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cytarabine
Description: injection
Study NCT04229979 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Observation
Description: palliative management
Study NCT04229979 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GM-CSF
Description: subcutaneous injection
Study NCT04229979 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Montanide
Description: adjuvant
Study NCT05155527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin Tablets
Description: 6 mg/tablet
Study NCT05155527 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo has same form as Ivermectin.
Study NCT06416722 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive-Motor Dual Task Activities
Description: Patients included in this group will be given additional cognitive tasks (e.g. counting months, subtracting 5 from 100) in accordance with the physiotherapist's commands simultaneously with balance and large amplitude functional activities (such as stepping forward-sideways-backwards, sitting and standing).
Study NCT06416722 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor-Motor Dual Task Activities
Description: Patients included in this group will be given additional motor tasks (e.g. passing the ball from the right hand to the left hand while standing on a soft surface, clapping) in accordance with the physiotherapist's commands simultaneously with balance and large amplitude functional activities (such as stepping forward-sideways-backwards, sitting and standing).
Study NCT06416722 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive-Motor & Motor-Motor Dual Task Activities
Description: Simultaneously with balance and large amplitude functional activities (such as stepping forwards-sideways-backwards, sitting and standing), patients included in this group will be given additional cognitive (e.g. counting while standing with feet closed) and motor (e.g. passing the ball from the right hand to the left hand while standing on a soft surface) tasks in accordance with the physiotherapist's commands.
Study NCT06440850 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06440850 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cobimetinib
Description: Given PO
Study NCT06467201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KSHN001126 150mg
Description: 6 subjects will receive single oral dose of 150mg
Study NCT06467201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KSHN001126 300mg
Description: 6 subjects will receive single oral dose of 300mg
Study NCT05320185 — intervention group
Intervention type: DEVICE
Intervention: RuiXin-CoronaryAI software
Description: RuiXin-CoronaryAI, based on Computed Tomography Angiography (CTA) and was independently designed by RaysightMed Inc., which has been already authorized by National Medical Products Administration (NMPA).
Study NCT06467201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KSHN001126 600mg
Description: 6 subjects will receive single oral dose of 600mg
Study NCT04752319 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BreEStim
Description: BreEStim will be applied for 10 to 20 minutes per session for multiple sessions
Study NCT04752319 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EStim
Description: EStim will be applied for 10 to 20 minutes per session for multiple sessions
Study NCT06115785 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy
Description: Cognitive Stimulation Therapy CST consists of 14 sessions, each session with different themes. The materials used in therapy will differ according to the characteristics of each theme. For example; In the theme of physical games, one of the individuals will be selected by voting, and each individual will be asked to choose a song suitable for the theme and introduce himself/herself to the music accompaniment. Then, a small table game will be prepared with the rackets and ball used for table tennis, and individuals will be able to play a round of table tennis with the researcher and their groupmates. Sessions 10 min. introductory part, 25 min. activity section and in progress10 min. 45 minutes in total, including the ending.
Study NCT06258564 — intervention group
Intervention type: BIOLOGICAL
Intervention: vaccination against human papillomavirus infection (HPV vaccination)
Description: Women with or without HPV vaccination before or after excision
Study NCT06468826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avacopan
Description: Oral capsules
Study NCT06264154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: E-cigarettes
Description: All participants are instructed to switch from smoking combustible cigarettes to using e-cigarettes for 6 weeks. Participants will receive an e-cigarette device and flavored nicotine pods according to their randomly assigned flavor.
Study NCT06264154 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: E-cigarettes
Description: All participants are instructed to switch from smoking combustible cigarettes to using e-cigarettes for 6 weeks. Participants will receive an e-cigarette device and flavored nicotine pods according to their randomly assigned flavor.
Study NCT04369326 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community-Based TPT Initiation
Description: Community-based care delivery model for pediatric tuberculosis evaluation and initiation of preventive therapy
Study NCT06549985 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PEEPS
Description: Participants will participate in the PEEPS program in addition to usual care.
Study NCT06549985 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Education
Description: Participants will receive an educational handout on endometriosis in addition to usual care.
Study NCT06346119 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: this arm will received relaxing touch (hands, feet, head) during 30 minutes twice a day
Description: Patients who will be included in this arm will receive massage twice a day of the head (10 minutes), feet (10 minutes) and hands (10 minutes)
Study NCT05249660 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Soft tissue release technique
Description: Patient sat on a chair. The therapist stood behind the participant and held one hand over head as the support, with the thumb of the other hand scan to detect the painful area of the latent TP of the upper trapezius muscle along the fibers. Then, pressure was applied by the thumb and the participant was asked to simultaneously actively change the muscle from shorted position to elongated state (ipsilateral side flexion of the cervical to the opposite side). This technique was repeated 3-5 times per session, and each repetition was maintained for 40-60 s till release is felt, with a 15-second rest interval. Three times passive stretching of the upper trapezius muscle was also performed for 45 s for each side.